Total skin electron beam radiotherapy for patients who have mycosis fungoides

Hematology/Oncology Clinics of North America

Volumn 17, Issue 6, 2003, Pages 1421-1434

  Jones, Glenn ^a,b,c   Wilson, Lynn D ^d   Fox Goguen, Lisa ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b JURAVINSKI CANCER CENTRE   (Canada)

^c Radiation Oncology   (Canada)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORMETHINE; PSORALEN;

CANCER CENTER; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL RESEARCH; ELECTRON BEAM; EXTRACORPOREAL PHOTOPHERESIS; HUMAN; MEDICAL DECISION MAKING; MYCOSIS FUNGOIDES; OUTCOMES RESEARCH; PRIORITY JOURNAL; PUBLICATION; PUVA; RADIATION DOSE; REVIEW; SURVIVAL TIME; TOTAL SKIN ELECTRON BEAM RADIOTHERAPY; TREATMENT INDICATION; TREATMENT PLANNING; ULTRAVIOLET RADIATION;

EID: 0345735909     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(03)00108-4     Document Type: Review

References (42)

1. Jones GW. Review: mycosis fungoides: issues and management in 1995. Cancer J (Paris) 1994;7:214-9.
2. Jones GW, Wilson LD. Mycosis fungoides and total skin electron beam radiation. Blood 1997;89:3062-4.
3. Jones GW, Hoppe RT, Glatstein E. Electron beam treatment for cutaneous T-cell lymphoma. Hematol Oncol Clin N Am 1995;9(5):1057-76.
4. Wilson LD, Jones GW, Kacinski BM, Heald PW. Mycosis fungoides. In: Gunderson LL, Tepper JE, editors. Clinical radiation oncology. 1st edition. Philadelphia: Churchill Livingstone; 2000. p. 1224-36.
5. Wilson LD, Jones GW, Kacinski GM, Edelson RL, Heald PW. Cutaneous T-cell lymphomas. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. 6th edition. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 2316-30.
6. Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe RT. Clinical stage IA (limited patch and plaque) mycosis fungoides: a long-term outcome analysis. Arch Dermatol 1996;132:1309-13.
7. Quiros PA, Kacinski BM, Wilson LD. Extent of skin involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T-cell lymphoma treated with total skin electron beam radiation therapy. Cancer 1996;77:1912-7.
8. Rosenblatt E, Kuten A, Leviov M, Cederbaum M. Total skin electron irradiation in mycosis fungoides dose and fractionation considerations. Leuk Lymph 1998;30:143-51.
9. Kirova YM, Piedbois Y, Haddad E, Levy E, Calitchi E, Marinello G, et al. Radiotherapy in the management of mycosis fungoides: indications, results, prognosis. Twenty years experience. Radiother Oncol 1999;51:147-51.
10. Jones GW, Rosenthal D, Wilson LD. Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sezary syndrome). Cancer 1999;85:1985-95.
11. Rampino M, Ragona R, Monetti U, Mussano A, Guameri A, Sannazzari GL. Total skin electron beam therapy in mycosis fungoides. Our experience from 1985-1999. Radiol Med (Torino) 2002;103:108-14.
12. van Doom R, Van Haselen CW, van Voorst Vader PC, Geerts ML, Heule F, de Rie M, et al. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol 2000;136:504-10.
13. Jones GW, Kacinski BM, Wilson LD, Willemze R, Spittle M, Hoheberg G, et al. Reports: total skin electron radiation in the management of mycosis fungoides: consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group. J Am Acad Dermatol 2002;47:364-70.
14. International Commission on Radiation Units and Measurements. Report 35: Radiation dosimetry: electron beams with energies between 1 and 50 MeV. Bethesda (MD): ICRU; 1984.
15. Micaily B, Vondereid EC, Brady LW, Andrews C. Total skin electron beam and total nodal irradiation for patients with cutaneous T-cell lymphoma. Internat J Radiat Oncol Biol Phys 1985;11:1111-5.
16. Micaily B, Campell O, Moser C, Vonderheid EC, Brady LW. Total skin electron beam and total nodal irradiation of cutaneous T-cell lymphoma. Internat J Radiat Oncol Biol Phys 1991;20:809-13.
17. Halberg FE, Fu KK, Weaver KA, Zackheim HS, Epstein Jr EH, Wintroub BU. Combined total body X-ray irradiation and total skin electron beam radiotherapy with an improved technique for mycosis fungoides. Internat J Radiat Oncol Biol Phys 1989;17:427-32.
18. Maingon P, True G, Dalac S, Barillot I, Lambert D, Petrella T, et al. Radiotherapy of advanced mycosis fungoides: indications and results of total skin electron beam and photon beam irradiation. Radiother Oncol 2000;54:73-8.
19. Jones GW, Thorson B. Cutaneous T-cell lymphoma (mycosis fungoides). Lancet 1996;348:130-1.
20. Kaye FJ, Bunn PA, Steinberg SM, Stocker JL, Ihde DC, Fischmann AB, et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989;321:1784-90.
21. Vonderheid EC, Van Scott EJ, Wallner PE, Johnson WC. A 10 year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total skin electron beam radiation therapy. Cancer Treat Rep 1979;63:681-9.
22. Hamminga B, Noordijk E, Van Vloten WA. Treatment of mycosis fungoides: total-skin electron-beam irradiation vs. topical mechlorethamine therapy. Arch Dermatol 1982;118:150-3.
23. Chinn DM, Chow S, Kim YH, Hoppe RT. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides. Internat J Radiat Oncol Biol Phys 1999;34:951-8.
24. Jones GW, Wilson LD. The changing survival of patients with mycosis fungoides. A population-based assessment of trends in the United States [correspondence]. Cancer 1999;86:1985-7.
25. Jones GW, Tadros A, Hodson DI, Rosenthal D, Roberts J, Thorson B. Prognosis with newly diagnosed mycosis fungoides after total skin electron radiation of 30 or 35 Gy. Internat J Radiat Oncol Biol Phys 1994;28(4):839-45.
26. Peters V, Jaywant SM. Implementation of total skin electron therapy using an optional high dose-rate mode on a conventional linear accelerator. Med Dosim 1995;20:99-104.
27. Jones GW, Maclean J, Rosenthal D, Roberts J, Sauder DN. Combined treatment with oral synthetic retinoids and electron beam therapy in patients with cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). J Am Acad Dermatol 1992;26:960-7.
28. Jones GW, Savilo E, Roberts JT, Rosenthal D. Infiltrative cell density in pre-irradiated skin as a prognostic factor in mycosis fungoides. J Clin Invest Med 1994;17:B119.
29. Zackheim HS. Time to treatment failure as an end point for cutaneous T-cell lymphoma. J Am Acad Dermatol 1998;38:283-4.
30. Wilson LD, Quiros PA, Kolenik SA, Heald PW, Braverman IM, Edelson RL, et al. Additional courses of total skin electron beam therapy in the retreatment of patients with cutaneous T-cell lymphoma. J Am Acad Dermatol 1996;35:69-73.
31. Becker M, Hoppe RT, Knox SJ. Multiple courses of high-dose total skin electron beam therapy in the management of mycosis fungoides. Internat J Radiat Oncol Biol Phys 1995;32:1445-9.
32. Suchin KR, Cucchiara AJ, Gottleib SL, Wolfe JT, DeNardo BJ, Macey WH, et al. Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution. Arch Dermatol 2002;138:1054-60.
33. Braverman IM, Yager NB, Chen M, Cadman EC, Hait WN, Maynard T. Combined total body electron beam irradiation and chemotherapy for mycosis fugnoides. J Am Acad Dermatol 1987;161:45-60.
34. Wilson LD, Licata AL, Braverman IM, Edelson RL, Heald PW, Feldman AM, et al. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy. Intemat J Radiat Oncol Biol Phys 1995;32:987-95.
35. Griem ML, Tokars RP, Petras V, Varialrojis D, Baron JM, Griem SF. Combined therapy for patients with mycosis fungoides. Cancer Treat Rep 1979;63:655-7.
36. Winkler CF, Sausville EA, Ihde DC, Fischman AB, Schechter GP, Kumar PP, et al. Combined modality treatment of cutaneous T-cell lymphoma: results of a six year follow-up. J Clin Oncol 1986;4:1094-100.
37. Hallahan DE, Griem ML, Medenica M, Soltani K, Lorincz AL, Baron JM. Combined modality therapy for tumor state mycosis fungoides. J Clin Oncol 1988;6:1177-83.
38. Duvic M, Lemak NA, Redman JR, Eifel PJ, Tucker SL, Cabanillas FF, et al. Combined modality therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1999;34:1022-9.
39. Wilson LD, Jones GW, Kim D, Rosenthal D, Christensen IR, Edelson RL, et al. Experience with total skin electron beam therapy in combination with extracorporeal photophersis in the management of patients with erythrodermic (T4) mycosis fungoides. J Am Acad Dermatol 2000;43:54-60.
40. Quiros PA, Jones GW, Kacinski BM, Braverman IM, Heald PW, Edelson RL, et al. Total skin electron beam therapy followed by adjuvant Psoralen/Ultraviolet A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides). Internat J Radiat Oncol Biol Phys 1997;35:1027-35.
41. Price NM, Hoppe RT, Constantine FS, Fuks ZY, Farber EM. The treatment of mycosis fungoides: adjuvant topical mechlorethamine after electron-beam therapy. Cancer 1977;40:2851-3.
42. Kim YH, Chow S, Varghese A, Hoppe RT. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Arch Dermatol 1999;135:26-32.